Goblet cell carcinoma
disease diseaseOn this page
Also known as appendix adenocarcinoid tumorappendix adenocarcinoid tumourappendix goblet cell carcinoidappendix goblet cell carcinoid tumorappendix goblet cell carcinoid tumourappendix mixed carcinoid-adenocarcinomacarcinoma of goblet cellGCCgoblet cell adenocarcinoidGoblet Cell Adenocarcinomagoblet cell carcinoidgoblet cell carcinoid of appendixgoblet cell carcinoid of the appendixgoblet cell carcinoid tumorgoblet cell carcinoid tumourgoblet cell tumorgoblet cell tumourmucinous carcinoidmucinous carcinoid tumor
Summary
Goblet cell carcinoma (MONDO:0018017) is a cancer. A subtype of neuroendocrine carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
- Prevalence: Unknown (Worldwide)
Clinical features
Epidemiology
Prevalence records
1 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Annual incidence | <1 / 1 000 000 | 0.025 | Worldwide | Not yet validated |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | goblet cell carcinoma |
| Mondo ID | MONDO:0018017 |
| Orphanet | 329984 |
| NCIT | C3689 |
| UMLS | C0205695 |
| MedGen | 60007 |
| GARD | 0010414 |
| NORD | 1931 |
| Is cancer (heuristic) | yes |
Also known as: appendix adenocarcinoid tumor · appendix adenocarcinoid tumour · appendix goblet cell carcinoid · appendix goblet cell carcinoid tumor · appendix goblet cell carcinoid tumour · appendix mixed carcinoid-adenocarcinoma · carcinoma of goblet cell · GCC · goblet cell adenocarcinoid · Goblet Cell Adenocarcinoma · goblet cell carcinoid · goblet cell carcinoid of appendix · goblet cell carcinoid of the appendix · goblet cell carcinoid tumor · goblet cell carcinoid tumour · goblet cell carcinoma · goblet cell tumor · goblet cell tumour · mucinous carcinoid · mucinous carcinoid tumor (+1 more)
Disease family
This is a subtype of neuroendocrine carcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › neuroendocrine carcinoma › goblet cell carcinoma
Related subtypes (11): small cell carcinoma, anal canal neuroendocrine neoplasm, large cell neuroendocrine carcinoma, pancreatic endocrine carcinoma, combined lung carcinoma, malignant adrenal gland pheochromocytoma, liver neuroendocrine carcinoma, medullary thyroid gland carcinoma, cutaneous neuroendocrine carcinoma, thymic neuroendocrine carcinoma, vulvar neuroendocrine carcinoma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.